FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....